Abstract:The considerable increase of investment in research and development by the pharmaceutical industry over the past three decades has not added the number of approved new drugs. An important issue ignored by drug discovery practice is the multi-dimensional interaction network between drugs and their targets. Thus, it is essential to view drug actions through the lens of network biology. In the current study, based on the co-expression network of transcription factors and their downstream genes, we proposed a novel approach, called causal co-expression method with module analysis, to screen drugs with specific target and fewer side effects. We presented a causal co-expression method with module analysis and it could be used in analyzing the microarray data of different drug candidates. At first, the differential wiring value (DW) was calculated to find some causal transcription factors (TFs) by combining with differential expression genes in the regulated networks. After the discovery of the causal TFs, co-expression module analysis method was applied to mine molecular pharmacology pathways around these causal TFs at molecular level. We applied our methods to two drug candidates, Argyrin A and Bortezomib, both with anti-cancer activities. We first obtained some differentially expressed transcription factors of cells treated with Argyrin A or Bortezomib. Nearly all these transcription factors are associated with the tumor suppressor protein p27kip1. Furthermore, module analysis showed that Bortezomib inhibited tumor growth not specifically by cell cycle and cell proliferation pathway, but through many basic metabolic processes which result in cell toxicity. In contrast, Argyrin A had influence on cell cycle, and was involved in DNA damage repair at the same time, showing that Argyrin A was a more suitable drug for anti-cancer treatment. Our study revealed that the causal co-expression method with module analysis was effective and can be used as a tool to evaluate drug candidates.

The Application of Cdna Microarrays Technology in Mechanism of Drug

Application of cDNA microarray in the mechanism analysis of drug

Screening for Candidate Genes Related to Breast Cancer with Cdna Microarray Analysis

Application of DNA Microarray Technologies in Neurotoxicology Research

APPLICATION OF DIFFERENT MICROARRAY ANALYSIS METHODS IN PHARMACOLOGICAL MECHANISM RESEARCH

Screening the Human Pancreatic Cancer-Associated Genes by Cdna Microarray

Gcncchip Technology and Its Application in Pharmacology

Study on Metastasis-Associated Gene in Carcinoma by Cdna Microarray

Cdna Microarray in Analysis of Pancreatic Cancer-Related Genes

Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray.

DNA Microarray Analysis of Gene Expression Profiles in Pancreatic Carcinoma

Analysis of Gene Expression Profiles in Pancreatic Carcinoma by Using Cdna Microarray.

Gene Chip Technology and Its Application in Investigation of Anticancer Medicament

Application of DNA microarray technology in immunological research and its inspiration to researches on traditional Chinese medicine

Effect of basil polysaccharide on rat model bearing NuTu- 19 cells

Use of three-color cDNA microarray experiments to assess the therapeutic and side effect of drugs

Differentially Expressed Genes in Normal Breast Tissue and Breast Cancer Tissue by Cdna Microarray

Cdna Microarray Technique in Screening Primary Drug Resistance-Related Genes of Human Malignant Glioma

Causal Co-Expression Method with Module Analysis to Screen Drugs with Specific Target.

Cluster Analysis of Gene Expression and Glioblastoma-Associated Gene by Using Cdna Microarray

Analysis of Gene Expression Patterns in Pancreatic Cancer by Cdna Micro Array